Influenza Diagnostics Market by Product (Test Kits, Instruments), Test Type (Traditional (RIDT, Viral Culture, Serological), Molecular (PCR, INAAT- NASBAT, TMABAS)), End User (Diagnostic Laboratories, Hospitals, Clinics), Region-Global Forecast to 2026

Influenza Diagnostics Market by Product (Test Kits, Instruments), Test Type (Traditional (RIDT, Viral Culture, Serological), Molecular (PCR, INAAT- NASBAT, TMABAS)), End User (Diagnostic Laboratories, Hospitals, Clinics), Region-Global Forecast to 2026

The global influenza diagnostics market is projected to reach USD 1.1 billion by 2026 from USD 0.8billion in 2021, at a CAGR of 7.7% during the forecast period. Market growth is driven by factors such as the growth in influenza research for diagnostic technologies,rising demand for rapid disease diagnosis and increasing prevalence of influenza. On the other hand, therising healthcare costs, variabilities in test sensitivity and specificityare the major factors hampering the growth of this market.

“The test kits and reagents segment accounted for the highest growth rate in theinfluenza diagnostics market, by product, during the forecast period”

Theinfluenza diagnostics market is segmented into test kits and reagents, instruments and other productsbased on product. In 2020, the test kits and reagents segment accounted for the highest growth rate in the influenza diagnostics market. Increasing prevalence of influenza and rising demand for rapid disease diagnosis are major factor contributing to the growth of this segment.

“The molecular diagnostic tests segment accounted for the highest growth rate in the influenza diagnostics market, by test type, during the forecast period”

The influenza diagnostics market is segmented into molecular diagnostic tests and traditional diagnostic tests based on test type. In 2020, the molecular diagnostic tests segment accounted for the highest growth rate in the influenza diagnostics market. Growth in influenza research for diagnostic technologies and rising demand for rapid disease diagnosis are major factor contributing to the growth of this segment.

“Diagnostic laboratories segment accounted for the highest CAGR”

Based onend user, the influenza diagnosticsmarket is segmented intodiagnostic laboratories, hospitals and clinics and other end users. In 2020, the hospitals and clinics segment accounted for the highest CAGR. This can be attributed to therising demand for rapid disease diagnosis and increasing prevalence of influenza.

“Asia Pacific: The fastest-growing regionin influenza diagnostics market”

The global influenza diagnostics market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period.Factors such as the rising demand for rapid disease diagnosis and growth in influenza research for diagnostic technologiesare driving the growth of the influenza diagnostics market in this region.

The primary interviews conducted for this report can be categorized as follows:
By Company Type: Tier 1 - 40%, Tier 2 - 30%,and Tier 3 -30%
By Designation: C-level - 27%, D-level - 18%, and Others - 55%
By Region: North America -51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and the Middle East & Africa – 4%

Lists of Companies Profiled in the Report:
Danaher Corporation (US)
Siemens Healthineers (Germany)
Thermo Fisher Scientific, Inc. (US)
F. Hoffmann-LA Roche AG (Switzerland)
Abbott Laboratories, Inc. (Us)
Hologic, Inc. (US)
bioMérieux SA (France)
Quidel Corporation (US)
Becton, Dickinson and Company (US)
Meridian Bioscience (US)
GenMark Diagnostics, Inc. (US)
Luminex Corporation (US)
Tecan Trading AG (Switzerland)
DiaSorin SA (Italy)
altona Diagnostics GmbH (Germany)
SEKISUI Diagnostics (US)
SA Scientific Ltd. (US)
CorisBioConcept SPRL (Belgium)
ELITech Group (France)
Mast Group Ltd. (UK)
Genome Diagnostics, Pvt. Ltd. (India)
Germaine Laboratories, Inc. (US)
Response Biomedical Corp. (Canada)
Tauns Laboratories, Inc. (Japan)
3B BlackBio Biotech India Ltd. (India)

Research Coverage:

This report provides a detailed picture of the global influenza diagnostics market. It aims at estimating the size and future growth potential of the market across different segments, such as product, test type, end userand region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall influenza diagnostics market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • INCLUSIONS & EXCLUSIONS OF THE STUDY
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
    • RESEARCH APPROACH
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
    • MARKET BREAKDOWN & DATA TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
    • GROWTH RATE ASSUMPTIONS
    • LIMITATIONS
    • RISK ASSESSMENT
    • COVID-19 HEALTH ASSESSMENT
    • COVID-19 ECONOMIC ASSESSMENT
    • ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • ASSESSMENT OF THE IMPACT OF COVID-19 ON THE INFLUENZA DIAGNOSTICS MARKET
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • INFLUENZA DIAGNOSTICS MARKET OVERVIEW
    • INFLUENZA DIAGNOSTICS MARKET SHARE, BY PRODUCT, 2021 VS. 2026
    • INFLUENZA DIAGNOSTICS MARKET SHARE, BY TEST TYPE, 2021 VS. 2026
    • INFLUENZA DIAGNOSTICS MARKET SHARE, BY END USER, 2021 VS. 2026
    • INFLUENZA DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
    • IMPACT OF COVID-19 ON THE INFLUENZA DIAGNOSTICS MARKET
    • PRICING ANALYSIS
      • Table PRICES OF INFLUENZA DIAGNOSTIC PRODUCTS (2021)
    • PATENT ANALYSIS
    • TRADE ANALYSIS
      • TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
        • Table IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016–2020 (USD MILLION)
        • Table EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016–2020 (USD MILLION)
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • ECOSYSTEM ANALYSIS OF THE INFLUENZA DIAGNOSTICS MARKET
      • ROLE IN THE ECOSYSTEM
    • PORTER'S FIVE FORCES ANALYSIS
      • Table INFLUENZA DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
      • THREAT FROM NEW ENTRANTS
      • THREAT FROM SUBSTITUTES
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • DEGREE OF COMPETITION
    • PESTLE ANALYSIS
    • REGULATORY LANDSCAPE
      • NORTH AMERICA
      • EUROPE
      • ASIA PACIFIC
      • LATIN AMERICA
      • MIDDLE EAST
      • AFRICA
    • TECHNOLOGY ANALYSIS
    • DISRUPTIVE TECHNOLOGIES IN THE INFLUENZA DIAGNOSTICS MARKET
      • REVENUE SHIFT & REVENUE POCKETS FOR THE INFLUENZA DIAGNOSTICS MARKET
  • INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT
    • INTRODUCTION
      • Table INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
    • TEST KITS & REAGENTS
      • REPEAT PURCHASE OF TEST KITS & REAGENTS TO DRIVE MARKET GROWTH IN THE COMING YEARS
        • Table INFLUENZA DIAGNOSTICS MARKET FOR TEST KITS & REAGENTS, BY REGION, 2019–2026 (USD MILLION)
    • INSTRUMENTS
      • INCREASING NEED FOR FASTER & MORE ACCURATE TEST RESULTS TO PROPEL MARKET GROWTH
        • Table KEY INSTRUMENTS IN THE INFLUENZA DIAGNOSTICS MARKET
        • Table INFLUENZA DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2019–2026 (USD MILLION)
    • OTHER PRODUCTS
      • Table INFLUENZA DIAGNOSTICS MARKET FOR OTHER PRODUCTS, BY REGION, 2019–2026 (USD MILLION)
  • INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE
    • INTRODUCTION
      • Table INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
    • MOLECULAR DIAGNOSTIC TESTS
      • Table MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
      • Table MOLECULAR DIAGNOSTIC TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
      • POLYMERASE CHAIN REACTION TESTS
        • Table POLYMERASE CHAIN REACTION TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
      • ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS
        • Table ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
        • Table TRANSCRIPTION-MEDIATED AMPLIFICATION-BASED ASSAYS MARKET, BY REGION, 2019–2026 (USD MILLION)
        • Table LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAYS MARKET, BY REGION, 2019–2026 (USD MILLION)
        • Table NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION ASSAYS MARKET, BY REGION, 2019–2026 (USD MILLION)
        • Table OTHER ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
      • OTHER MOLECULAR DIAGNOSTIC TESTS
        • Table OTHER MOLECULAR DIAGNOSTIC TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
    • TRADITIONAL DIAGNOSTIC TESTS
      • Table TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
      • Table TRADITIONAL DIAGNOSTIC TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
      • RAPID INFLUENZA DIAGNOSTIC TESTS
        • Table RAPID INFLUENZA DIAGNOSTIC TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
      • VIRAL CULTURE TESTS
        • Table VIRAL CULTURE TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
      • DIRECT FLUORESCENT ANTIBODY TESTS
        • Table DIRECT FLUORESCENT ANTIBODY TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
      • SEROLOGICAL TESTS
        • Table SEROLOGICAL TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
  • INFLUENZA DIAGNOSTICS MARKET, BY END USER
    • INTRODUCTION
      • Table INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
    • DIAGNOSTIC LABORATORIES
      • LARGE NUMBER OF INFLUENZA DIAGNOSTIC TESTS PERFORMED IN DIAGNOSTIC LABORATORIES TO DRIVE MARKET GROWTH
        • Table INFLUENZA DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2019–2026 (USD MILLION)
    • HOSPITALS & CLINICS
      • GROWING GLOBAL NUMBER OF HOSPITALS DUE TO INCREASING INFECTIOUS DISEASE INCIDENCE TO DRIVE MARKET GROWTH
        • Table INFLUENZA DIAGNOSTICS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019–2026 (USD MILLION)
    • OTHER END USERS
      • Table INFLUENZA DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION)
  • INFLUENZA DIAGNOSTICS MARKET, BY REGION
    • INTRODUCTION
      • Table INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
      • Table INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
    • NORTH AMERICA
      • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
      • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
      • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
      • Table NORTH AMERICA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
      • Table NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
      • Table NORTH AMERICA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
      • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • US
        • Table US: PRODUCT APPROVALS IN THE INFLUENZA DIAGNOSTICS MARKET
        • Table US: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        • Table US: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
        • Table US: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table US: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table US: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • CANADA
        • Table CANADA: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        • Table CANADA: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
        • Table CANADA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table CANADA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table CANADA: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
    • EUROPE
      • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
      • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
      • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
      • Table EUROPE: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
      • Table EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
      • Table EUROPE: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
      • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • GERMANY
        • Table GERMANY: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        • Table GERMANY: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
        • Table GERMANY: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table GERMANY: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table GERMANY: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • ITALY
        • Table ITALY: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        • Table ITALY: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
        • Table ITALY: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table ITALY: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table ITALY: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • FRANCE
        • Table FRANCE: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        • Table FRANCE: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
        • Table FRANCE: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table FRANCE: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table FRANCE: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • SPAIN
        • Table SPAIN: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        • Table SPAIN: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
        • Table SPAIN: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table SPAIN: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table SPAIN: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • UK
        • Table UK: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        • Table UK: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
        • Table UK: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table UK: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table UK: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        • Table ROE: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
        • Table ROE: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table ROE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table ROE: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table ROE: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: INFLUENZA DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
      • Table ASIA PACIFIC: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
      • Table ASIA PACIFIC: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
      • Table ASIA PACIFIC: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
      • Table ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
      • Table ASIA PACIFIC: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
      • Table ASIA PACIFIC: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • CHINA
        • Table CHINA: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        • Table CHINA: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
        • Table CHINA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table CHINA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table CHINA: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • JAPAN
        • Table JAPAN: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        • Table JAPAN: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
        • Table JAPAN: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table JAPAN: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table JAPAN: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • INDIA
        • Table INDIA: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        • Table INDIA: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
        • Table INDIA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table INDIA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table INDIA: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table ROAPAC: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        • Table ROAPAC: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
        • Table ROAPAC: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table ROAPAC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table ROAPAC: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table ROAPAC: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
    • LATIN AMERICA
      • RISING DISEASE PREVALENCE AND INCREASING HEALTHCARE EXPENDITURE TO DRIVE THE LATAM MARKET
        • Table LATIN AMERICA: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        • Table LATIN AMERICA: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
        • Table LATIN AMERICA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table LATIN AMERICA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table LATIN AMERICA: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • RISING ACCESS TO ADVANCED TECHNOLOGIES AND GROWING INVESTMENTS WILL SUPPORT MARKET GROWTH
        • Table MIDDLE EAST & AFRICA: INFLUENZA DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: INFLUENZA DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • KEY PLAYER STRATEGIES/RIGHT TO WIN
      • OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE INFLUENZA DIAGNOSTICS MARKET
        • Table STRATEGIES ADOPTED BY KEY INFLUENZA DIAGNOSTIC PRODUCT MANUFACTURING COMPANIES
    • REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • MARKET SHARE ANALYSIS
      • Table INFLUENZA DIAGNOSTICS MARKET: DEGREE OF COMPETITION
    • COMPANY EVALUATION QUADRANT
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
    • COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES (2020)
      • PROGRESSIVE COMPANIES
      • STARTING BLOCKS
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
    • COMPETITIVE BENCHMARKING
      • Table COMPANY PRODUCT FOOTPRINT
      • Table COMPANY REGIONAL FOOTPRINT
    • COMPETITIVE SCENARIO
      • PRODUCT LAUNCHES & APPROVALS
        • Table KEY PRODUCT LAUNCHES & APPROVALS
      • DEALS
        • Table KEY DEALS
  • COMPANY PROFILES
    • KEY PLAYERS
      • THERMO FISHER SCIENTIFIC, INC.
        • Table THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
      • BECTON, DICKINSON AND COMPANY
        • Table BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
      • F. HOFFMANN-LA ROCHE AG
        • Table F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
      • HOLOGIC, INC.
        • Table HOLOGIC, INC.: BUSINESS OVERVIEW
      • ABBOTT LABORATORIES, INC.
        • Table ABBOTT LABORATORIES, INC.: BUSINESS OVERVIEW
      • DANAHER CORPORATION
        • Table DANAHER CORPORATION: BUSINESS OVERVIEW
      • QUIDEL CORPORATION
        • Table QUIDEL CORPORATION: BUSINESS OVERVIEW
      • SIEMENS HEALTHINEERS
        • Table SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
      • BIOMÉRIEUX SA
        • Table BIOMÉRIEUX SA: BUSINESS OVERVIEW
      • MERIDIAN BIOSCIENCE
        • Table MERIDIAN BIOSCIENCE: BUSINESS OVERVIEW
    • OTHER PLAYERS
      • GENMARK DIAGNOSTICS, INC.
      • LUMINEX CORPORATION
      • TECAN TRADING AG
      • DIASORIN SA
      • ALTONA DIAGNOSTICS GMBH
      • SEKISUI DIAGNOSTICS
      • SA SCIENTIFIC, LTD.
      • CORIS BIOCONCEPT SPRL
      • ELITECH GROUP
      • MAST GROUP LTD.
      • GENOME DIAGNOSTICS PVT. LTD.
      • GERMAINE LABORATORIES, INC.
      • RESPONSE BIOMEDICAL CORP.
      • TAUNS LABORATORIES, INC.
      • 3B BLACKBIO BIOTECH INDIA LTD.
  • APPENDIX
    • INSIGHTS FROM INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook